Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/24
End: 05/31/29
Due: 05/31/30
Phase: N/A
Priority: Normal
Start: 01/04/22
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 08/31/19
Due: 08/31/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | NCT06217302 | Alessandro Doria | user2@example.com | None | 2024-10-31 | 2029-05-31 | 2030-05-31 | - | - | 2025-07-14 |
| A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes | NCT04929379 | Alessandro Doria | user2@example.com | None | 2022-01-04 | 2025-08-01 | 2026-08-01 | - | - | 2025-07-14 |
| A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes | NCT02017171 | Alessandro Doria | user2@example.com | None | 2014-02-28 | 2019-08-31 | 2020-08-31 | - | - | 2025-07-14 |